RIGL

Rigel Pharmaceuticals, Inc. is a biotechnology company based in South San Francisco, California, specializing in the discovery and development of novel small molecule drugs aimed at addressing critical unmet medical needs in blood disorders, cancer, and rare immune diseases. With a strong focus on innovative therapies, Rigel leverages its proprietary drug development platform to advance its pipeline of targeted treatments, aiming to improve patient outcomes in challenging therapeutic areas. The company is committed to addressing significant health challenges through scientific innovation and strategic partnerships within the healthcare sector.